Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov;24(9 Suppl 3):S61-6.
doi: 10.1097/IGC.0000000000000261.

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas

Martee L Hensley  1 , Brigitte A Barrette, Klaus Baumann, David Gaffney, Anne L Hamilton, Jae-Weon Kim, Johanna U Maenpaa, Patricia Pautier, Nadeem Ahmad Siddiqui, Anneke M Westermann, Isabelle Ray-Coquard
Affiliations
Review

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas

Martee L Hensley et al. Int J Gynecol Cancer. 2014 Nov.

Abstract

Objectives: The Gynecologic Cancer InterGroup aimed to provide an overview of uterine and ovarian leiomyosarcoma management.

Methods: Published articles and author experience were used to draft management overview. The draft manuscript was circulated to international members of the Gynecologic Cancer InterGroup for review and comment, and appropriate revisions were made.

Results: The approach to management of uterine and ovarian leiomyosarcoma management is reviewed.

Conclusions: Uterine and ovarian leiomyosarcomas are rare and aggressive cancers that require specialized expertise for optimal management.

PubMed Disclaimer

References

    1. Koivisto-Korander R, Martinsen JI, Weiderpass E, Leminen A, Pukkala E. Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. Maturitas. 2012 May;72:56–60. - PubMed
    1. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008;112:820. - PubMed
    1. Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat RR, Brennan MF, Hensley ML. Stage specific outcomes of patients with uterine leiomyosarcoma: a comparison of the FIGO and AJCC staging systems. J Clin Oncol. 2009;27:2066–2072. - PMC - PubMed
    1. Serrano C, Oduyebo T, Manola J, Feng Y, Muto M, George S. Impact of tumor morcellation on the natural history of uterine leiomyosarcoma. Connective Tissue Oncology Society. 2013 Abstract 011.
    1. Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, Haie-Meder C, Duvillard P. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer. 2000;88(6):1425–1431. - PubMed